Literature DB >> 29075846

Postoperative outcome and quality of life after surgery for FAP-associated duodenal adenomatosis.

Petra Ganschow1,2, Thilo Hackert3, Marcel Biegler3, Pietro Contin3, Ulf Hinz3, Markus W Büchler3, Martina Kadmon3.   

Abstract

INTRODUCTION: Prophylactic colon surgery has increased life expectancy of familial adenomatous polyposis patients. Extracolonic manifestations are life limiting, above all duodenal adenomas. Severe duodenal adenomatosis or cancer may necessitate pancreas-preserving total duodenectomy or partial pancreatico-duodenectomy, mostly after previous proctocolectomy and often after limited local resections of duodenal adenomas. Scarce information on long-term postoperative outcome and quality of life after surgery for duodenal adenomatosis is available. Aim of the present study was to analyze perioperative and long-term outcome after PD and PPTD for FAP-associated duodenal adenomatosis, including QoL and recurrence of adenomas in the neoduodenum after PPTD. MATERIAL, METHODS AND PATIENTS: Thirty-eight patients, 27 after pancreas-preserving duodenectomy and 11 after partial pancreaticoduodenectomy, were included.
RESULTS: Pancreas-preserving total duodenectomy was associated with shorter operation time and less blood loss than partial pancreatico-duodenectomy. Clinically relevant pancreatic fistula occurred in 31.5%. In-hospital mortality was 5.3%. Long-term follow-up revealed recurrent pancreatitis after pancreas-preserving total duodenectomy in 22% of patients, two (7.4%) required re-operation. Recurrent adenomatosis was detected in 26% of patients. Quality of life was comparable to the German normal population after both surgical procedures. Patients with postoperative complications showed worse results than those without complications. Disease-specific 10-year survival rate with respect to duodenal adenomatosis was 100%.
CONCLUSION: Surgery for FAP-associated duodenal adenomatosis and cancer can be carried out with reasonable morbidity rates despite previous proctocolectomy. Long-term outcome, quality of life, and survival rates are favorable.

Entities:  

Keywords:  Duodenal adenomas; FAP; Pancreas-preserving total duodenectomy; Partial pancreaticoduodenectomy; Whipple-procedure

Mesh:

Year:  2017        PMID: 29075846     DOI: 10.1007/s00423-017-1625-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  38 in total

1.  [The SF-36 in the Federal Health Survey--description of a current normal sample].

Authors:  U Ellert; B M Bellach
Journal:  Gesundheitswesen       Date:  1999-12

2.  Severe duodenal involvement in familial adenomatous polyposis treated by pylorus-preserving pancreaticoduodenectomy.

Authors:  Frédéric Caillié; François Paye; Benoit Desaint; Malika Bennis; Jérémie H Lefèvre; Yann Parc; Magali Svrcek; Pierre Balladur; Emmanuel Tiret
Journal:  Ann Surg Oncol       Date:  2012-02-04       Impact factor: 5.344

Review 3.  [Preventive surgery for familial adenomatous polyposis coli].

Authors:  M Kadmon
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

Review 4.  Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis.

Authors:  O Aziz; T Athanasiou; V W Fazio; R J Nicholls; A W Darzi; J Church; R K S Phillips; P P Tekkis
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

Review 5.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.

Authors:  Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler
Journal:  Surgery       Date:  2016-12-28       Impact factor: 3.982

6.  New pancreas-preserving total duodenectomy technique.

Authors:  Masayuki Imamura; Izumi Komoto; Ryuichiro Doi; Hisashi Onodera; Hiroyuki Kobayashi; Yasuhiro Kawai
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

7.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

8.  Pancreas-preserving total duodenectomy: a 10-year experience.

Authors:  Luit Penninga; Lars Bo Svendsen
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-09       Impact factor: 7.027

Review 9.  Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  D Korolija; S Sauerland; S Wood-Dauphinée; C C Abbou; E Eypasch; M García Caballero; M A Lumsden; B Millat; J R T Monson; G Nilsson; R Pointner; W Schwenk; A Shamiyeh; A Szold; E Targarona; B Ure; E Neugebauer
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

10.  Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps.

Authors:  B Al-Sarireh; P Ghaneh; J Gardner-Thorpe; M Raraty; M Hartley; R Sutton; J P Neoptolemos
Journal:  Br J Surg       Date:  2008-12       Impact factor: 6.939

View more
  2 in total

1.  Efficacy of endoscopic retrograde cholangiopancreatography in familial adenomatous polyposis patients after duodenectomy.

Authors:  Ravi S Shah; Neal Mehta; Carol A Burke; Gautam Mankaney; Tyler Stevens; Toms Augustin; Matthew R Walsh; Amit Bhatt
Journal:  DEN open       Date:  2022-01-06

2.  Acarbose improved survival for Apc+/Min mice.

Authors:  Sherry G Dodds; Manish Parihar; Martin Javors; Jia Nie; Nicolas Musi; Zelton Dave Sharp; Paul Hasty
Journal:  Aging Cell       Date:  2020-01-06       Impact factor: 9.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.